 |
  
|
  |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
FDA Approves Drug for Cryptococcal Meningitis in HIV PatientsSummer 2000 A note from TheBody.com: Since this article was written, the HIV pandemic has changed, as has our understanding of HIV/AIDS and its treatment. As a result, parts of this article may be outdated. Please keep this in mind, and be sure to visit other parts of our site for more recent information! Deerfield, Ill., July 5 (Reuters) -- The US Food and Drug Administration approved the antifungal drug AmBisome for the treatment of cryptococcal meningitis in HIV-infected patients, Fujisawa Healthcare Inc. and Gilead Sciences Inc. said Wednesday. Cryptococcal meningitis is a life-threatening infection of the membranes lining the brain and spinal cord and occurs when a patient is exposed to the fungus cryptococcus neofor-mans. The organism can infect almost all organs in the body but most commonly causes disease of the spinal cord, skin or lungs. The majority of people with cryptococcal meningitis have immune systems that are damaged by disease, such as AIDS, or suppressed by medications. It affects 5 to 10 percent of people infected with HIV.
Back to the Women Alive Summer 2000 Contents Page.
A note from TheBody.com: Since this article was written, the HIV pandemic has changed, as has our understanding of HIV/AIDS and its treatment. As a result, parts of this article may be outdated. Please keep this in mind, and be sure to visit other parts of our site for more recent information!  This article was provided by Women Alive. It is a part of the publication Women Alive Newsletter.
|
|
Email
Print-Friendly
Glossary
The Body: About The Body | Contact The Body | Content Policy | Content Providers | Advertise With Us | Site Map
Remedy Health Media: About Remedy Health Media | Contact Remedy Health Media | Terms of Use | Privacy Policy
The Body is a service of Remedy Health Media, LLC, 250 West 57th Street, New York, NY 10107. The Body and its logos are trademarks of Remedy Health Media, LLC, and its subsidiaries, which owns the copyright of The Body's homepage, topic pages, page designs and HTML code. General Disclaimer: The Body is designed for educational purposes only and is not engaged in rendering medical advice or professional services. The information provided through The Body should not be used for diagnosing or treating a health problem or a disease. It is not a substitute for professional care. If you have or suspect you may have a health problem, consult your health care provider.
